Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...
The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...
RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...
Common and highly contagious illnesses are reaching several-month highs. Norovirus has almost reached a several-year record.